SCHEMBL30973764

CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O[C@H]1[C@@H](O)[C@](C#N)(c2ccc3c(NC(=O)[C@H](C)C(C)C)ncnn23)O[C@@H]1COC(=O)Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	TMPRSS2	O15393	1/20	0.38

▸	GLS	O94925	1/20	0.32

▸	PTPN1	P18031	4/20	0.32

▸	CDC25B	P30305	4/20	0.32

▸	PTPN2	P17706	2/20	0.32

▸	CDC25A	P30304	2/20	0.32

▸	KLK5	Q9Y337	1/20	0.30

▸	CTSS	P25774	2/20	0.30

▸	CTSL	P07711	1/20	0.30

▸	CTSB	P07858	1/20	0.30

▸	CTSK	P43235	1/20	0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30973736	1.00	TMPRSS2 (0.38)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL25922652	0.96	TMPRSS2 (0.39)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL30603771	0.95	TMPRSS2 (0.39)	TMPRSS2
SCHEMBL30603724	0.95	TMPRSS2 (0.39)	TMPRSS2
SCHEMBL30973779	0.94	TMPRSS2 (0.38)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL27413367	0.94	TMPRSS2 (0.38)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL24916988	0.94	TMPRSS2 (0.39)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL30973730	0.92	TMPRSS2 (0.39)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL24916999	0.92	TMPRSS2 (0.38)	TMPRSS2GLSPTPN1CDC25BPTPN2
SCHEMBL30973784	0.92	TMPRSS2 (0.39)	TMPRSS2GLSPTPN1CDC25BPTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2024129963-A1	ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS	VenatoRx Pharmaceuticals, Inc. (US)	2024-06-20	—	—	WO	disclosed